CATALYST PHARMACEUTICALS INC Share Price Today: Live Updates & Key Insights
CATALYST PHARMACEUTICALS INC share price today is $22.75, up 2.06%. The stock opened at $22.21 against the previous close of $22.33, with an intraday high of $22.85 and low of $22.21.
CATALYST PHARMACEUTICALS INC Share Price Chart
CATALYST PHARMACEUTICALS INC
CATALYST PHARMACEUTICALS INC Share Price Performance
CATALYST PHARMACEUTICALS INC Institutional Holdings
CATALYST PHARMACEUTICALS INC Market Status
CATALYST PHARMACEUTICALS INC Fundamentals
Market Cap 2801.17 M
PB Ratio 2.9166
PE Ratio 13.3275
Enterprise Value 2076.82 M
Total Assets 1106.81 M
Volume 3188853
CATALYST PHARMACEUTICALS INC Company Financials
About CATALYST PHARMACEUTICALS INC & investment objective
Company Information Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States. It offers Firdapse for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); Fycompa, a novel non-competitive selective antagonist at the postsynaptic ionotropic alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid glutamate receptor that is used to treat focal onset seizures, as well as tonic-clonic seizure; and AGAMREE, a corticosteroid for the treatment of duchenne muscular dystrophy. The company has license agreements with BioMarin Pharmaceutical Inc.; and a collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida.
Organisation Biotechnology
Employees 182
Industry Biotechnology
CEO Mr. Richard John Daly M.B.A.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
CATALYST PHARMACEUTICALS INC FAQs
What is the share price of CATALYST PHARMACEUTICALS INC today?
The current share price of CATALYST PHARMACEUTICALS INC is $22.75.
Can I buy CATALYST PHARMACEUTICALS INC shares in India?
Yes, Indian investors can buy CATALYST PHARMACEUTICALS INC shares by opening an international trading and demat account with Motilal Oswal.
How to buy CATALYST PHARMACEUTICALS INC shares in India?
You can easily invest in CATALYST PHARMACEUTICALS INC shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy CATALYST PHARMACEUTICALS INC shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of CATALYST PHARMACEUTICALS INC.
Can I buy fractional shares of CATALYST PHARMACEUTICALS INC?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of CATALYST PHARMACEUTICALS INC?
CATALYST PHARMACEUTICALS INC has a market cap of $2801.17 M.
In which sector does CATALYST PHARMACEUTICALS INC belong?
CATALYST PHARMACEUTICALS INC operates in the Biotechnology sector.
What documents are required to invest in CATALYST PHARMACEUTICALS INC stocks?
To invest, you typically need:
What is the PE and PB ratio of CATALYST PHARMACEUTICALS INC?
The PE ratio of CATALYST PHARMACEUTICALS INC is 13.33 and the PB ratio is 2.92.